Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS) (2020)
Attributed to:
Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ehjci/ehaa946.1735
Publication URI: http://dx.doi.org/10.1093/ehjci/ehaa946.1735
Type: Journal Article/Review
Parent Publication: European Heart Journal
Issue: Supplement_2